Purchased Services, Clinical and Biomedical, Research
Regeneron to Acquire 23andMe Out of Bankruptcy for $256 Million
Regeneron; 23andMe; acquisition; bankruptcy; genetic testing; genome; personal genome service; total health; research services; data privacy